Annual long term liabilities:
$208.21M+$72.61M(+53.55%)Summary
- As of today (July 27, 2025), NTLA annual total long term liabilities is $208.21 million, with the most recent change of +$72.61 million (+53.55%) on December 31, 2024.
- During the last 3 years, NTLA annual long term liabilities has risen by +$79.82 million (+62.17%).
- NTLA annual long term liabilities is now at all-time high.
Performance
NTLA Long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly long term liabilities:
$93.65M-$114.56M(-55.02%)Summary
- As of today (July 27, 2025), NTLA quarterly total long term liabilities is $93.65 million, with the most recent change of -$114.56 million (-55.02%) on March 31, 2025.
- Over the past year, NTLA quarterly long term liabilities has dropped by -$31.89 million (-25.40%).
- NTLA quarterly long term liabilities is now -55.02% below its all-time high of $208.21 million, reached on December 31, 2024.
Performance
NTLA quarterly long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Long term liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
NTLA Long term liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +53.5% | -25.4% |
| 3 y3 years | +62.2% | -23.8% |
| 5 y5 years | +623.8% | +195.5% |
NTLA Long term liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +62.2% | -55.0% | at low |
| 5 y | 5-year | at high | +623.8% | -55.0% | +28.2% |
| alltime | all time | at high | >+9999.0% | -55.0% | +225.6% |
NTLA Long term liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $93.65M(-55.0%) |
| Dec 2024 | $208.21M(+53.5%) | $208.21M(+98.2%) |
| Sep 2024 | - | $105.05M(-9.0%) |
| Jun 2024 | - | $115.38M(-8.1%) |
| Mar 2024 | - | $125.54M(-7.4%) |
| Dec 2023 | $135.60M(-14.2%) | $135.60M(+19.0%) |
| Sep 2023 | - | $113.98M(-3.8%) |
| Jun 2023 | - | $118.50M(-4.2%) |
| Mar 2023 | - | $123.66M(-21.7%) |
| Dec 2022 | $157.98M(+23.0%) | $157.98M(+23.1%) |
| Sep 2022 | - | $128.38M(+21.0%) |
| Jun 2022 | - | $106.12M(-13.7%) |
| Mar 2022 | - | $122.92M(-4.3%) |
| Dec 2021 | $128.39M(+51.1%) | $128.39M(-1.5%) |
| Sep 2021 | - | $130.30M(+25.9%) |
| Jun 2021 | - | $103.47M(-6.2%) |
| Mar 2021 | - | $110.32M(+29.8%) |
| Dec 2020 | $85.00M | $85.00M(+16.3%) |
| Sep 2020 | - | $73.07M(-8.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2020 | - | $80.10M(+152.8%) |
| Mar 2020 | - | $31.69M(+10.2%) |
| Dec 2019 | $28.77M(-0.2%) | $28.77M(-14.0%) |
| Sep 2019 | - | $33.46M(-9.8%) |
| Jun 2019 | - | $37.11M(-9.0%) |
| Mar 2019 | - | $40.79M(+41.5%) |
| Dec 2018 | $28.82M(-34.9%) | $28.82M(-10.1%) |
| Sep 2018 | - | $32.05M(-9.1%) |
| Jun 2018 | - | $35.27M(-8.3%) |
| Mar 2018 | - | $38.46M(-13.1%) |
| Dec 2017 | $44.28M(-24.2%) | $44.28M(-6.9%) |
| Sep 2017 | - | $47.54M(-6.8%) |
| Jun 2017 | - | $51.02M(-6.3%) |
| Mar 2017 | - | $54.47M(-6.7%) |
| Dec 2016 | $58.40M(-37.0%) | $58.40M(-3.8%) |
| Sep 2016 | - | $60.71M(-7.2%) |
| Jun 2016 | - | $65.41M(-28.7%) |
| Mar 2016 | - | $91.72M(-1.0%) |
| Dec 2015 | $92.64M(>+9900.0%) | $92.64M |
| Dec 2014 | $773.00K | - |
FAQ
- What is Intellia Therapeutics, Inc. annual total long term liabilities?
- What is the all time high annual long term liabilities for Intellia Therapeutics, Inc.?
- What is Intellia Therapeutics, Inc. annual long term liabilities year-on-year change?
- What is Intellia Therapeutics, Inc. quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Intellia Therapeutics, Inc.?
- What is Intellia Therapeutics, Inc. quarterly long term liabilities year-on-year change?
What is Intellia Therapeutics, Inc. annual total long term liabilities?
The current annual long term liabilities of NTLA is $208.21M
What is the all time high annual long term liabilities for Intellia Therapeutics, Inc.?
Intellia Therapeutics, Inc. all-time high annual total long term liabilities is $208.21M
What is Intellia Therapeutics, Inc. annual long term liabilities year-on-year change?
Over the past year, NTLA annual total long term liabilities has changed by +$72.61M (+53.55%)
What is Intellia Therapeutics, Inc. quarterly total long term liabilities?
The current quarterly long term liabilities of NTLA is $93.65M
What is the all time high quarterly long term liabilities for Intellia Therapeutics, Inc.?
Intellia Therapeutics, Inc. all-time high quarterly total long term liabilities is $208.21M
What is Intellia Therapeutics, Inc. quarterly long term liabilities year-on-year change?
Over the past year, NTLA quarterly total long term liabilities has changed by -$31.89M (-25.40%)